Recurrence of immunological markers for type 1 (insulin-dependent) diabetes mellitus in immunosuppressed patients after pancreas transplantation

Transplantation

Volumn 66, Issue 1, 1998, Pages 128-131

  Esmatjes, Enric ^a   Rodríguez Villar, Camino ^b   Ricart, Maria J ^b   Casamitjana, Roser ^b   Martorell, Jaume ^b   Sabater, Lluis ^b   Astudillo, Emiliano ^b   Fernández Cruz, Laureano ^b  

^a HOSPITAL CLÍNIC   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; INSULIN; OKT 3; PREDNISONE; THYMOCYTE ANTIBODY;

ADULT; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL ARTICLE; DIABETES MELLITUS; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL;

ADULT; ANTIBODIES; BIOLOGICAL MARKERS; DIABETES MELLITUS, TYPE 1; FEMALE; GLUTAMATE DECARBOXYLASE; HUMANS; IMMUNOSUPPRESSION; ISLETS OF LANGERHANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PANCREAS TRANSPLANTATION; RECURRENCE;

EID: 0344301902     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199807150-00022     Document Type: Article

References (11)

1. Bonifacio E, Bingley P, Shattock M, et al. Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes. Lancet 1990; 335: 147.
2. Atkinson MA, Maclaren NK, Scharp DW, Lacy PE, Riley WJ. 64,000 Mr autoantibodies as predictors of insulin-dependent diabetes. Lancet 1990; 335: 1357.
3. Gorsuch AN, Spencer KM, Lister J, McNally JM, Dean BM, Bottazzo FG. Evidence for a long prediabetic period in type 1 (insulin dependent) diabetes mellitus. Lancet 1981; 2: 1363.
4. Ziegler AG, Herbowitz RD, Jackson RA, Soelner JS, Eisenbarth GS. Predicting type 1 diabetes. Diabetes Care 1990; 13: 762.
5. The ICARUS Data Set. Interactions of age, islet cell antibodies, insulin autoantibodies, and first-phase insulin response in predicting risk of progression to IDDM in ICA+ relatives. Diabetes 1996; 45: 1720.
6. Sutherland DER, Goetz FC, Sibley RK. Recurrence of disease in pancreas transplants. Diabetes 1989; 38(suppl 1): 85.
7. Tyden G, Reinholt FP, Sundkvist G, Bolinder J. Recurrence of autoimmune diabetes mellitus in recipients of cadaveric pancreatic grafts. N Engl J Med 1996; 335: 860.
8. Bosi E, Bottazzo GF, Secchi A, et al. Islet cell autoimmunity in type 1 diabetic patients after HLA-mismatched pancreas transplantation. Diabetes 1989; 38(suppl 1): 82.
9. 65 and IA-2 specific autoantibodies in recipients of pancreas/renal transplants [Abstract]. Diabetologia 1996; 39: 239A.
10. Mandrup-Poulsen T, Molvig J, Andersen HU, Helqvist S, Spinas GA, Munck M. Lack of predictive value of islet cell antibodies, insulin antibodies, and HLA-DR phenotype for remission in cyclosporin-treated IDDM patients: The Canadian-European Randomized Control Trial Group. Diabetes 1990; 39: 204.
11. Rewers M, Bugawan TL, Noris JM, et al. Newborn screening for HLA markers associated with IDDM: diabetes autoimmunity study in the young (DAISY). Diabetologia 1996; 39: 807.